Cargando…
TIMP-1 and CD82, a promising combined evaluation marker for PDAC
Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a widely secreted protein that regulates cell motility, proliferation, and apoptosis. Although it is recognized that TIMP-1–tetraspanin CD63 regulates epithelial cell apoptosis and proliferation, how TIMP-1 controls cell motility is not well under...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351648/ https://www.ncbi.nlm.nih.gov/pubmed/28030805 http://dx.doi.org/10.18632/oncotarget.14133 |
_version_ | 1782514802382340096 |
---|---|
author | Zhang, Jiexin Wu, Tijun Zhan, Shanshan Qiao, Nan Zhang, Xu Zhu, Yunxia Yang, Nan Sun, Yujie Zhang, Xin A Bleich, David Han, Xiao |
author_facet | Zhang, Jiexin Wu, Tijun Zhan, Shanshan Qiao, Nan Zhang, Xu Zhu, Yunxia Yang, Nan Sun, Yujie Zhang, Xin A Bleich, David Han, Xiao |
author_sort | Zhang, Jiexin |
collection | PubMed |
description | Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a widely secreted protein that regulates cell motility, proliferation, and apoptosis. Although it is recognized that TIMP-1–tetraspanin CD63 regulates epithelial cell apoptosis and proliferation, how TIMP-1 controls cell motility is not well understood. In this study, we identify tetraspanin CD82 (also called KAI1) as a component of the promiscuous TIMP-1 interacting protein complex on cell surface of human pancreatic adenocarcinoma cells. CD82 directly binds to TIMP-1 N-terminal region through its large extracellular loop and co-localizes with TIMP-1 in both cancer cell lines and clinical samples. Moreover, CD82 facilitates membrane-bound TIMP-1 endocytosis, which significantly contributes to the anti-migration effect of TIMP-1. CD82 silencing partially eliminates these functions. TIMP-1 and CD82 expression status in patients with pancreatic ductal adenocarcinoma (PDAC) might demonstrate future usefulness as a differentiation marker and give us new insight into tumorigenic metastatic potential. |
format | Online Article Text |
id | pubmed-5351648 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53516482017-04-13 TIMP-1 and CD82, a promising combined evaluation marker for PDAC Zhang, Jiexin Wu, Tijun Zhan, Shanshan Qiao, Nan Zhang, Xu Zhu, Yunxia Yang, Nan Sun, Yujie Zhang, Xin A Bleich, David Han, Xiao Oncotarget Research Paper Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a widely secreted protein that regulates cell motility, proliferation, and apoptosis. Although it is recognized that TIMP-1–tetraspanin CD63 regulates epithelial cell apoptosis and proliferation, how TIMP-1 controls cell motility is not well understood. In this study, we identify tetraspanin CD82 (also called KAI1) as a component of the promiscuous TIMP-1 interacting protein complex on cell surface of human pancreatic adenocarcinoma cells. CD82 directly binds to TIMP-1 N-terminal region through its large extracellular loop and co-localizes with TIMP-1 in both cancer cell lines and clinical samples. Moreover, CD82 facilitates membrane-bound TIMP-1 endocytosis, which significantly contributes to the anti-migration effect of TIMP-1. CD82 silencing partially eliminates these functions. TIMP-1 and CD82 expression status in patients with pancreatic ductal adenocarcinoma (PDAC) might demonstrate future usefulness as a differentiation marker and give us new insight into tumorigenic metastatic potential. Impact Journals LLC 2016-12-24 /pmc/articles/PMC5351648/ /pubmed/28030805 http://dx.doi.org/10.18632/oncotarget.14133 Text en Copyright: © 2017 Zhang et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Zhang, Jiexin Wu, Tijun Zhan, Shanshan Qiao, Nan Zhang, Xu Zhu, Yunxia Yang, Nan Sun, Yujie Zhang, Xin A Bleich, David Han, Xiao TIMP-1 and CD82, a promising combined evaluation marker for PDAC |
title | TIMP-1 and CD82, a promising combined evaluation marker for PDAC |
title_full | TIMP-1 and CD82, a promising combined evaluation marker for PDAC |
title_fullStr | TIMP-1 and CD82, a promising combined evaluation marker for PDAC |
title_full_unstemmed | TIMP-1 and CD82, a promising combined evaluation marker for PDAC |
title_short | TIMP-1 and CD82, a promising combined evaluation marker for PDAC |
title_sort | timp-1 and cd82, a promising combined evaluation marker for pdac |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351648/ https://www.ncbi.nlm.nih.gov/pubmed/28030805 http://dx.doi.org/10.18632/oncotarget.14133 |
work_keys_str_mv | AT zhangjiexin timp1andcd82apromisingcombinedevaluationmarkerforpdac AT wutijun timp1andcd82apromisingcombinedevaluationmarkerforpdac AT zhanshanshan timp1andcd82apromisingcombinedevaluationmarkerforpdac AT qiaonan timp1andcd82apromisingcombinedevaluationmarkerforpdac AT zhangxu timp1andcd82apromisingcombinedevaluationmarkerforpdac AT zhuyunxia timp1andcd82apromisingcombinedevaluationmarkerforpdac AT yangnan timp1andcd82apromisingcombinedevaluationmarkerforpdac AT sunyujie timp1andcd82apromisingcombinedevaluationmarkerforpdac AT zhangxina timp1andcd82apromisingcombinedevaluationmarkerforpdac AT bleichdavid timp1andcd82apromisingcombinedevaluationmarkerforpdac AT hanxiao timp1andcd82apromisingcombinedevaluationmarkerforpdac |